XPost: alt.fan.rush-limbaugh, alt.atheism, talk.politics.guns
XPost: or.politics, sci.physics

he should make the scientists pay all that money back

This is by Musk's authority. Soon they will give him unfettered powers
of arrest and we will cheer.


Trump Team Dismantles Efforts to Find a Cure for Cancer and Other Deadly Disorders and Diseases

Move to Slash Scientific Research Institutions Funded by the National Institutes of Health is in Direct Violation of the Law

WASHINGTON — President Trump’s Administration is imposing a new policy to
cap indirect costs for National Institutes of Health (NIH) research
grants at 15 percent, which would cut billions of dollars in funding for life-saving research to develop cures and treatments for diseases. Under
the leadership of House Appropriations Committee and Labor, Health and
Human Services, and Education Subcommittee Ranking Member Rosa DeLauro, Congress enacted a provision that has been included annually in
appropriations bills since 2018 that explicitly prohibits any
Administration from making these changes.

“Once again, President Trump and Elon Musk are acting in direct violation
of the law. In this case, they are causing irreparable damage to ongoing research to develop cures and treatments for cancer, Alzheimer’s disease
and related dementias, ALS, Diabetes, Mental Health disorders, opioid
abuse, genetic diseases, rare diseases, and other diseases and conditions affecting American families,” said Ranking Member Rosa DeLauro. “The
Trump Administration is attempting to steal critical funds promised to scientific research institutions funded by the NIH, despite an explicit
legal prohibition against this action.”

In 2017, the first Trump Administration proposed to cut funding for NIH research by approximately $6 billion, or nearly 20 percent. President
Trump’s proposal would have cut funding for cancer research by nearly $1 billion and imposed across-the-board cuts to every other area of life-
saving research. Not surprisingly, the proposal was met by universal opposition, including opposition by Republicans as well as Democrats.

On October 24, 2017, the House Appropriations Committee held a
congressional hearing on the topic of cuts to NIH-funded research
institutions. The Committee invited experts from across the
country—including Oklahoma, Connecticut, California, and the State of Washington—representing a range of research institutions that conduct biomedical research. In their congressional testimony, these experts laid
out in meticulous detail the shared costs, known as “facilities and administrative (F&A) costs,” that are associated with world-class
research that makes the United States the global leader in developing
cures and treatments for diseases and other health conditions. These
shared F&A costs are a necessary component of any world-class research
program. They include costs for laboratories, scientific libraries,
equipment, maintenance, utilities, security, and support staff. These are shared research costs that are not covered by funds provided in an
individual research grant.

As a result of this congressional hearing, the House Appropriations
Committee collaborated with the Senate Appropriations Committee—both
Democrats and Republicans—to add a new provision to the annual
appropriations bill that funds the National Institutes of Health. The new provision explicitly prohibited the Administration from imposing changes
to NIH’s existing policy to fund F&A costs at research institutions. The provision has been included annually in appropriations bills since 2018.
The current provision reads as follows:

“SEC. 224. In making Federal financial assistance, the provisions
relating to indirect costs in part 75 of title 45, Code of Federal
Regulations, including with respect to the approval of deviations from negotiated rates, shall continue to apply to the National Institutes of
Health to the same extent and in the same manner as such provisions were applied in the third quarter of fiscal year 2017. None of the funds appropriated in this or prior Acts or otherwise made available to the Department of Health and Human Services or to any department or agency
may be used to develop or implement a modified approach to such
provisions, or to intentionally or substantially expand the fiscal effect
of the approval of such deviations from negotiated rates beyond the proportional effect of such approvals in such quarter.”

“Based on this legal statute, which is clear and unequivocal, Musk and
the Trump Administration are prohibited from implementing its new policy
to cut funding for biomedical research that was approved by Congress.It
is my expectation that a federal judge will block the Administration’s
most recent illegal action,” DeLauro continued. “President Trump is
taking an axe to our efforts to find cures to diseases and disorders that
are tearing apart families across the country. President Trump and Elon
Musk’s proposal to cut billions of dollars for research institutions will
cost lives and put the United States on a path to decline. They must immediately reverse this unlawful policy.”

--- SoupGate-Win32 v1.05
* Origin: fsxNet Usenet Gateway (21:1/5)